John J. Alam, EVP, Medicines Development, & CMO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 1,500 shares at $35.46 ($53K) on 2007-01-31, disclosed to the SEC on 2007-02-01.
Scheduled sale ($53k) by EVP, Medicines Development, & CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.46 | 500 | $18K | 33.3% |
| 2 | $35.46 | 1,000 | $35K | 66.7% |
| Total | $35.46 avg | 1,500 | $53K | 100% |
| Filing → |
| CRVO | BUY | 2025-11-13 | $41K | — | Filing → |
| VRTX | SELL | 2008-10-02 | $139K | — | Filing → |
| VRTX | SELL | 2008-09-11 | $173K | — | Filing → |